Latest News

Journal Articles

Autoimmune

Can living in a sunnier climate in your youth reduce the risk of MS?

Could transcranial direct current stimulation offer relief from fatigue in multiple sclerosis sufferers?

Multiple sclerosis research suggests a neuroprotective benefit following resistance training

Cerebrovascular disease

Novartis to seek US approval of siponimod for SPMS: industry news round up

Could Kineret® reduce inflammation in stroke patients?

Stroke Administrative Severity Index: using administrative data for 30-day poststroke outcomes prediction

CNS/PNS/SNS

AAN 2018: Investigational drug offers hope for spinal muscular atrophy

New pathways identified in restricting CNS axonal regeneration

Researchers discover first non-gene mutations behind neurodevelopmental disorders

Cognitive/neurodegenerative disorders

AAN 2018: Investigational drug offers hope for spinal muscular atrophy

Azeliragon fails Phase III trial for Alzheimer’s disease: industry news round-up

World Parkinson’s Day: the year so far in Parkinson’s research – a note from the Editor

Demyelinating disease

Novartis to seek US approval of siponimod for SPMS: industry news round up

Siponimod could improve outcome in patients with SPMS

Stem cell transplant could be ‘game changer’ for MS patients

Development and pediatrics

AAN 2018: Investigational drug offers hope for spinal muscular atrophy

Researchers discover first non-gene mutations behind neurodevelopmental disorders

Nuclear receptor defects linked to autism spectrum disorders

Epilepsy and seizure

Epilepsy and cannabinoids: current consensus, controversies and future outlook

Reports of brain damage call a halt to Bellicum trials: industry news round-up

Could novel epileptic encephalopathy genes promote advances in treatment strategy?

Genetics

New pathways identified in restricting CNS axonal regeneration

Novartis to seek US approval of siponimod for SPMS: industry news round up

Researchers discover first non-gene mutations behind neurodevelopmental disorders

Headache

AAN 2018: Novel therapy for ‘difficult-to-treat’ migraines revealed

Novartis to seek US approval of siponimod for SPMS: industry news round up

Latest erenumab trial signals hope for refractory migraine sufferers

Immune disorders and inflammation

Analysis of three studies looks at the role of octagam® for chronic inflammatory demyelinating polyneuropathy patients

NCTalks at SfN17: Doris Doudet on Parkinson's, inflammation and the gut

Depression, anxiety, and stress severities in multiple sclerosis patients using injectable vs. oral treatments

Infection

NCTalks at SfN17: Kijun Yoon gives a Zika update

SfN17: CRISPR and iPSCs – new techniques to study the brain

Infographic: The facts about Zika

Injury/trauma

Study indicates all degrees of concussion may increase the risk of Parkinson’s disease

Is there a link between traumatic brain injury and dementia?

First blood test for concussion assessment wins FDA approval

Movement disorders

AAN 2018: Nerve stimulation device may help relieve essential tremors in the hand

Study indicates all degrees of concussion may increase the risk of Parkinson’s disease

Age/disease duration influence on activities of daily living and quality of life after levodopa-carbidopa intestinal gel in Parkinson's disease

Neuro-ophthalmology

Vision in Alzheimer's disease: a focus on the anterior afferent pathway

Glaucoma research gives a glimpse of a novel neuroprotection mechanism

Management of glaucoma as a neurodegenerative disease

Neurometabolic

Epigenetics, opioids and immune regulation: interviews from SfN17

Jeffrey Iliff: glymphatics, Alzheimer’s and future directions

SfN17: Neurodegeneration and the microbiome – new research highlights

Neuromuscular

New genetic suspects identified for ALS and FTD

Novel discovery in motor neuron disease may pave the way for future treatments

EAN 2017: Guillain-Barré syndrome risk associated with month of birth

Neuropsychiatry

Novel study reveals ‘fast-acting benefits’ of ketamine for depression

ALKS 5461 receives refusal-to-file for depression: industry news round-up

Could caffeine worsen symptoms associated with Alzheimer’s disease?

Oncology/tumor

Could Huntington’s disease act as an anti-cancer tool?

World Cancer Day: the year’s biggest breakthroughs in neuro-oncology

Could IGF-I levels play a neuroprotective role in patients with large vestibular schwannomas?

Pain

Analysis of three studies looks at the role of octagam® for chronic inflammatory demyelinating polyneuropathy patients

Epigenetics, opioids and immune regulation: interviews from SfN17

SfN17: Updates on stemming pain and understanding opioid abuse

Sleep

#NCIntroduces... Sleep science

Better sleep works like a dream at reducing fear learning

Sleep research realizes the dream of understanding brain plasticity mechanisms